Literature DB >> 407579

Isolation of virus-free Herpesvirus saimiri antigen-positive plasma membrane vesicles.

G R Pearson, R E Scott.   

Abstract

Experiments were undertaken to determine whether virus-free, antigen-positive plasma membrane vesicles could be isolated from owl monkey kidney cells infected with Herpesvirus saimiri. The results demonstrate that vesicles can be produced by using a vesiculation fluid containing 25 mM formaldehyde/2 mM dithiothreitol. Electron microscopy revealed that these vesicles were free of detectable virus particles. Vesicles prepared from the infected cells contained virus-induced membrane antigens as shown by membrane immunofluorescence and by inhibition of antibody-dependent lymphocyte cytotoxicity. Nonhuman primates immunized with vesicles produced antibodies to these membrane antigens, late cytoplasmic antigens, and neutralizing antibodies. Infectious virus was not demonstrated in these vesicles by cocultivation with owl monkey kidney cells or by the inoculation of cottontop marmosets. Furthermore, no DNA could be demonstrated in vesicles prepared from Herpesvirus-infected owl monkey kidney cells. The implication of these findings in relation to the question of a virus-free membrane vaccine against Herpesvirus infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407579      PMCID: PMC432210          DOI: 10.1073/pnas.74.6.2546

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Augmentation of lymphocyte cytotoxicity by antibody to herpesvirus saimiri associated antigens.

Authors:  J Prevost; T W Orr; G R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

2.  New member of the herpesvirus group isolated from wild cottontail rabbits.

Authors:  H C Hinze
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

3.  Plasma membrane vesiculation: a new technique for isolation of plasma membranes.

Authors:  R E Scott
Journal:  Science       Date:  1976-11-12       Impact factor: 47.728

4.  Intracellular and membrane immunofluorescence investigations on cells infected with Herpesvirus saimiri.

Authors:  G Pearson; D Ablashi; T Orr; H Rabin; G Armstrong
Journal:  J Natl Cancer Inst       Date:  1972-11       Impact factor: 13.506

5.  Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling.

Authors:  D Silvestre; F M Kourilsky; G Klein; Y Yata; C Neauport-Sautes; J P Levy
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

6.  Vaccination of non-human primates against malignant lymphoma.

Authors:  R Laufs; H Steinke
Journal:  Nature       Date:  1975-01-03       Impact factor: 49.962

7.  Immunological and virological investigations on owl monkeys infected with Herpesvirus saimiri.

Authors:  G R Pearson; H Rabin; W C Wallen; R H Neubauer; T W Orr; J L Cicmanec
Journal:  J Med Primatol       Date:  1974       Impact factor: 0.667

8.  Alterations of the immunological specificity of plasma membranes from cells infected with Marek's disease and turkey herpes viruses.

Authors:  O R Kaaden; B Dietzschold
Journal:  J Gen Virol       Date:  1974-10       Impact factor: 3.891

9.  Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys.

Authors:  G Klein; G Pearson; A Rabson; D V Ablashi; L Falk; L Wolfe; F Dienhardt; H Rabin
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

10.  Antibody responses to membrane antigens in monkeys infected with Herpesvirus saimiri.

Authors:  J M Prevost; G R Pearson; W C Wallen; H Rabin; L F Qualtiere
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

View more
  1 in total

Review 1.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.